These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 34972087)

  • 1. Patterns of recurrence according to the extent of resection in patients with IDH-wild-type glioblastoma: a retrospective study.
    Yoo J; Yoon SJ; Kim KH; Jung IH; Lim SH; Kim W; Yoon HI; Kim SH; Sung KS; Roh TH; Moon JH; Park HH; Kim EH; Suh CO; Kang SG; Chang JH
    J Neurosurg; 2022 Aug; 137(2):533-543. PubMed ID: 34972087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival benefit of lobectomy over gross-total resection without lobectomy in cases of glioblastoma in the noneloquent area: a retrospective study.
    Roh TH; Kang SG; Moon JH; Sung KS; Park HH; Kim SH; Kim EH; Hong CK; Suh CO; Chang JH
    J Neurosurg; 2020 Mar; 132(3):895-901. PubMed ID: 30835701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncological and functional outcomes of supratotal resection of IDH1 wild-type glioblastoma based on
    Hirono S; Ozaki K; Kobayashi M; Hara A; Yamaki T; Matsutani T; Iwadate Y
    Sci Rep; 2021 Jul; 11(1):14554. PubMed ID: 34267303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of extent of resection for recurrent glioblastoma on overall survival: clinical article.
    Bloch O; Han SJ; Cha S; Sun MZ; Aghi MK; McDermott MW; Berger MS; Parsa AT
    J Neurosurg; 2012 Dec; 117(6):1032-8. PubMed ID: 23039151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgical outcome and molecular pattern characterization of recurrent glioblastoma multiforme: A single-center retrospective series.
    Montemurro N; Fanelli GN; Scatena C; Ortenzi V; Pasqualetti F; Mazzanti CM; Morganti R; Paiar F; Naccarato AG; Perrini P
    Clin Neurol Neurosurg; 2021 Aug; 207():106735. PubMed ID: 34119900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incorporating genomic signatures into surgical and medical decision-making for elderly glioblastoma patients.
    Ene CI; Cimino PJ; Fine HA; Holland EC
    Neurosurg Focus; 2020 Oct; 49(4):E11. PubMed ID: 33002863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rethinking extent of resection of contrast-enhancing and non-enhancing tumor: different survival impacts on adult-type diffuse gliomas in 2021 World Health Organization classification.
    Park YW; Kim S; Han K; Ahn SS; Moon JH; Kim EH; Kim J; Kang SG; Kim SH; Lee SK; Chang JH
    Eur Radiol; 2024 Feb; 34(2):1376-1387. PubMed ID: 37608093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraoperative MRI for newly diagnosed supratentorial glioblastoma: a multicenter-registry comparative study to conventional surgery.
    Shah AS; Sylvester PT; Yahanda AT; Vellimana AK; Dunn GP; Evans J; Rich KM; Dowling JL; Leuthardt EC; Dacey RG; Kim AH; Grubb RL; Zipfel GJ; Oswood M; Jensen RL; Sutherland GR; Cahill DP; Abram SR; Honeycutt J; Shah M; Tao Y; Chicoine MR
    J Neurosurg; 2021 Aug; 135(2):505-514. PubMed ID: 33035996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endonasal endoscopic reoperation for residual or recurrent craniopharyngiomas.
    Dhandapani S; Singh H; Negm HM; Cohen S; Souweidane MM; Greenfield JP; Anand VK; Schwartz TH
    J Neurosurg; 2017 Feb; 126(2):418-430. PubMed ID: 27153172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraoperative perception and estimates on extent of resection during awake glioma surgery: overcoming the learning curve.
    Lau D; Hervey-Jumper SL; Han SJ; Berger MS
    J Neurosurg; 2018 May; 128(5):1410-1418. PubMed ID: 28731401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal extent of resection for glioblastoma according to site, extension, and size: a population-based study in the temozolomide era.
    Kim YJ; Lee DJ; Park CK; Kim IA
    Neurosurg Rev; 2019 Dec; 42(4):937-950. PubMed ID: 30612289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Extent of Resection on Survival of Patients with Glioblastoma, IDH-Wild-Type, WHO Grade 4 (WHO 2021): Systematic Review and Meta-Analysis.
    Jusue-Torres I; Lee J; Germanwala AV; Burns TC; Parney IF
    World Neurosurg; 2023 Mar; 171():e524-e532. PubMed ID: 36529434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term surgical outcomes of intracranial epidermoid tumors: impact of extent of resection on recurrence and functional outcomes in 63 patients.
    Hasegawa H; Vakharia K; Carlstrom LP; Van Gompel JJ; Driscoll CLW; Carlson ML; Meyer FB; Link MJ
    J Neurosurg; 2022 Jun; 136(6):1592-1600. PubMed ID: 34653989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Supratotal Resection of Glioblastoma: Better Survival Outcome than Gross Total Resection.
    Baik SH; Kim SY; Na YC; Cho JM
    J Pers Med; 2023 Feb; 13(3):. PubMed ID: 36983564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is There a Role for Surgical Resection of Multifocal Glioblastoma? A Retrospective Analysis of 100 Patients.
    Friso F; Rucci P; Rosetti V; Carretta A; Bortolotti C; Ramponi V; Martinoni M; Palandri G; Zoli M; Badaloni F; Franceschi E; Asioli S; Fabbri VP; Rustici A; Foschini MP; Brandes AA; Mazzatenta D; Sturiale C; Conti A
    Neurosurgery; 2021 Nov; 89(6):1042-1051. PubMed ID: 34662898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of the extent of resection on the survival of patients with grade II and III gliomas using awake brain mapping.
    Motomura K; Chalise L; Ohka F; Aoki K; Tanahashi K; Hirano M; Nishikawa T; Yamaguchi J; Shimizu H; Wakabayashi T; Saito R
    J Neurooncol; 2021 Jun; 153(2):361-372. PubMed ID: 34009509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of the Extent of Resection With Survival in Glioblastoma: A Systematic Review and Meta-analysis.
    Brown TJ; Brennan MC; Li M; Church EW; Brandmeir NJ; Rakszawski KL; Patel AS; Rizk EB; Suki D; Sawaya R; Glantz M
    JAMA Oncol; 2016 Nov; 2(11):1460-1469. PubMed ID: 27310651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA methylation subclasses predict the benefit from gross total tumor resection in IDH-wildtype glioblastoma patients.
    Drexler R; Schüller U; Eckhardt A; Filipski K; Hartung TI; Harter PN; Divé I; Forster MT; Czabanka M; Jelgersma C; Onken J; Vajkoczy P; Capper D; Siewert C; Sauvigny T; Lamszus K; Westphal M; Dührsen L; Ricklefs FL
    Neuro Oncol; 2023 Feb; 25(2):315-325. PubMed ID: 35868257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extent of resection affects prognosis for patients with glioblastoma in non-eloquent regions.
    Kow CY; Kim BJH; Park TI; Chen JCC; Vong CK; Kim JY; Shim V; Dragunow M; Heppner P
    J Clin Neurosci; 2020 Oct; 80():242-249. PubMed ID: 33099354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extent of resection, molecular signature, and survival in 1p19q-codeleted gliomas.
    Garton ALA; Kinslow CJ; Rae AI; Mehta A; Pannullo SC; Magge RS; Ramakrishna R; McKhann GM; Sisti MB; Bruce JN; Canoll P; Cheng SK; Sonabend AM; Wang TJC
    J Neurosurg; 2021 May; 134(5):1357-1367. PubMed ID: 32384274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.